Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous-cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis
Abstract Background The ADAURA study indicated that adjuvant TKI therapy improves survival in postoperative patients with EGFR-mutated (EGFRm) non-small-cell lung cancer (NSCLC), especially in stage III disease. However, the effect of PORT for stage III (N2) NSCLC with different EGFR statuses remain...
Saved in:
| Main Authors: | Yunsong Liu, Yu Men, Xu Yang, Shuang Sun, Yongxing Bao, Zeliang Ma, Yang Wang, Yirui Zhai, Jianyang Wang, Lei Deng, Wenqing Wang, Nan Bi, Luhua Wang, Zhouguang Hui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Radiation Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13014-025-02592-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of Plasma Exosomal DNA for Detecting EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
by: Mohammad Mehdi Jahani, et al.
Published: (2025-04-01) -
Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway
by: Han Wang, et al.
Published: (2024-05-01) -
Detection of EGFR gene mutations for prescription of targeted drugs for non-small cell lung cancer
by: O. N. Pavlova, et al.
Published: (2024-04-01) -
Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study
by: Kaicheng Pan, et al.
Published: (2025-04-01) -
Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability
by: Huiling Su, et al.
Published: (2025-02-01)